|
1
|
Martin EG, Kelly C and Richard BL: Genomic
profiling of advanced non-small cell lung cancer in community
settings: Gaps and opportunities. Clin Lung Cancer. 18:651–659.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sabari JK, Montecalvo J, Chen R, Dienstag
JA, Mrad C, Bergagnini I, Victoria Lai WC, Arbour KC, Shu CA,
Hellmann MD, et al: PD-L1 expression and response to immunotherapy
in patients with MET exon 14-altered non-small cell lung cancers
(NSCLC). J Clin Oncol. 35:8512. 2017. View Article : Google Scholar
|
|
3
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nawaz K and Webster RM: The non-small-cell
lung cancer drug market. Nat Rev Drug Discov. 15:229–231. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ettinger DS, Akerley W, Borghaei H, Chang
AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK,
Govindan R, et al: Non-small cell lung cancer. J Natl Compr Canc
Netw. 10:1236–1271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:17–29. 2006. View Article : Google Scholar
|
|
7
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu X, Bao J, Wang Z, Zhang Z, Gu P, Tao F,
Cui D and Jiang W: The plasma lncRNA acting as fingerprint in
non-small-cell lung cancer. Tumor Biol. 37:3497–3504. 2016.
View Article : Google Scholar
|
|
10
|
Zhao X, Liu Y and Yu S: Long noncoding RNA
AWPPH promotes hepatocellular carcinoma progression through YBX1
and serves as a prognostic biomarker. Biochim Biophys Acta Mol
Basis Dis. 1863:1805–1816. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu F, Zhang X, Yu Q, Han G, Diao F, Wu C
and Zhang Y: LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate
bladder cancer progression. J Cell Biochem. 119:4496–4505. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Postmus PE, Kerr KM, Oudkerk M, Senan S,
Waller DA, Vansteenkiste J, Escriu C and Peters S; ESMO Guidelies
Committee, : Early and locally advanced non-small-cell lung cancer
(NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 28 (Suppl_4):iv1–iv21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'brien PJ, Slaughter MR, Polley SR and
Kramer K: Advantages of glutamate dehydrogenase as a blood
biomarker of acute hepatic injury in rats. Lab Anim. 36:313–321.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Devaux Y, Zangrando J, Schroen B, Creemers
EE, Pedrazzini T, Chang CP, Dorn GW II, Thum T and Heymans S;
Cardiolinc network, : Long noncoding RNAs in cardiac development
and ageing. Nat Rev Cardiol. 12:415–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu L, Xu H, Luo F, Liu X, Lu X, Yang Q,
Xue J, Chen C, Shi L and Liu Q: Epigenetic silencing of miR-218 by
the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle
transition in the malignant transformation of HBE cells induced by
cigarette smoke extract. Toxicol Appl Pharmacol. 304:30–41. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mayfield RD: Emerging roles for ncRNAs in
alcohol use disorders. Alcohol. 60:31–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uematsu K, He B, You L, Xu Z, McCormick F
and Jablons DM: Activation of the Wnt pathway in non-small cell
lung cancer: Evidence of disheveled overexpression. Oncogene.
22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim
SH, Huang E, Gao Y, Yang K, Wagner ER, et al: Tetrandrine inhibits
Wnt/β-catenin signaling and suppresses tumor growth of human
colorectal cancer. Mol Pharmacol. 79:211–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
